Guanfacine extended release for attention-deficit/hyperactivity disorder following inadequate response to prior methylphenidate

被引：1
|
作者：
Huss, M. [1 ]
Hervas, A. [2 ]
Newcorn, J. H. [3 ]
Harpin, V. [4 ]
Lyne, A. [5 ]
Robertson, B. [6 ]
Sikirica, V. [7 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Dept Child & Adolescent Psychiat, D-55122 Mainz, Germany
[2] Univ Hosp Mutua Terrassa UETD, Hosp St Joan de Deu, Child & Adolescent Mental Hlth Unit, Barcelona, Spain
[3] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA
[4] Ryegate Childrens Ctr, Sheffield, S Yorkshire, England
[5] Shire, Stat, Basingstoke, Hants, England
[6] Shire, Clin Dev, Wayne, NJ USA
[7] Shire, Global Hlth Econ Outcomes Res & Epidemiol, Wayne, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)71172-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.7.d.013
引用
收藏
页码：S727 / S728
页数：2
相关论文
共 50 条
  • [21] Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder
    Pagerols, M.
    Richarte, V.
    Sanchez-Mora, C.
    Garcia-Martinez, I.
    Corrales, M.
    Corominas, M.
    Cormand, B.
    Casas, M.
    Ribases, M.
    Ramos-Quiroga, J. A.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (01): : 98 - 104
  • [22] Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder
    Newcorn, Jeffrey H.
    Huss, Michael
    Connor, Daniel F.
    Hervas, Amaia
    Werner-Kiechle, Tamara
    Robertson, Brigitte
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2020, 41 (07): : 565 - 570
  • [23] Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder
    M Pagerols
    V Richarte
    C Sánchez-Mora
    I Garcia-Martínez
    M Corrales
    M Corominas
    B Cormand
    M Casas
    M Ribasés
    J A Ramos-Quiroga
    The Pharmacogenomics Journal, 2017, 17 : 98 - 104
  • [24] Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Spencer, Thomas J.
    Greenbaum, Michael
    Ginsberg, Lawrence D.
    Murphy, William Rory
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (05) : 501 - 510
  • [25] The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder
    Meyers, Juliana
    Gajria, Kavita
    Candrilli, Sean D.
    Fridman, Moshe
    Sikirica, Vanja
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (02) : 109 - 125
  • [26] Efficacy of Guanfacine Extended Release in the Treatment of Combined and Inattentive Only Subtypes of Attention-Deficit/Hyperactivity Disorder
    Sallee, Floyd R.
    Kollins, Scott H.
    Wigal, Timothy L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (03) : 206 - 214
  • [27] Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial
    Sallee, Floyd R.
    McGgough, James
    Wigal, Tim
    Donahue, Jessica
    Lyne, Andrew
    Biederman, Joseph
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2009, 48 (02): : 155 - 165
  • [28] Effects of Guanfacine Extended Release on Secondary Measures in Children With Attention-Deficit/Hyperactivity Disorder and Oppositional Symptoms
    Sallee, Floyd
    Spencer, Thomas
    Connor, Daniel
    Lopez, Frank
    Lyne, Andrew
    Tremblay, Gerald
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 149S - 149S
  • [29] Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder
    Huss, Michael
    McBurnett, Keith
    Cutler, Andrew J.
    Hervas, Amaia
    Bliss, Caleb
    Gao, Joseph
    Dirks, Bryan
    Newcorn, Jeffrey H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (03) : 432 - 443
  • [30] Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder
    Erder, M.
    Xie, Jipan
    Signorovitch, James
    Chen, Kristina
    Hodgkins, Paul
    Lu, Mei
    Wu, Eric
    Sikirica, Vanja
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2012, 10 (06) : 381 - 395
12345